These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8486432)

  • 21. Alkaline phosphatase activity in mouse teratoma.
    Berstine EG; Hooper ML; Grandchamp S; Ephrussi B
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3899-903. PubMed ID: 4521215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of cell-cell interaction upon differentiation of murine embryonal carcinoma cells].
    Sun JJ; Campione-Piccardo J; Craig J; McBurney MW
    Zhonghua Zhong Liu Za Zhi; 1987 Jan; 9(1):2-5. PubMed ID: 3595420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of teratocarcinoma cell differentiation. Effect of the inhibitors of DNA synthesis.
    Nishimune Y; Kume A; Ogiso Y; Matsushiro A
    Exp Cell Res; 1983 Jul; 146(2):439-44. PubMed ID: 6192006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A ts T mutant of Schmidt Ruppin strain of Rous sarcoma virus restricted at 39.5 degrees C for the morphological transformation and the tumorigenicity of chicken embryo fibroblasts.
    Poirier F; Lawrence D; Vigier P; Jullien P
    Int J Cancer; 1982 Jan; 29(1):69-76. PubMed ID: 6277805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ad5 12S growth factor induces F9 cell proliferation and differentiation.
    Quinlan MP
    Oncogene; 1989 Aug; 4(8):1051-5. PubMed ID: 2569707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.
    Kondo K; Watanabe T; Sasaki H; Uehara Y; Oishi M
    J Cell Biol; 1989 Jul; 109(1):285-93. PubMed ID: 2745553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine embryonal carcinoma cells differentiate in vitro in response to retinol.
    Eglitis MA; Sherman MI
    Exp Cell Res; 1983 Jul; 146(2):289-96. PubMed ID: 6683658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyoma virus mutants as probes of variety among mouse embryonal carcinoma cell lines.
    Georges E; Vasseur M; Blangy D
    Differentiation; 1982; 22(1):62-5. PubMed ID: 6286399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of embryonal carcinoma cells in response to retinoids.
    Abarzúa P; Sherman MI
    Methods Enzymol; 1990; 189():337-48. PubMed ID: 2292944
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines.
    McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI
    Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of the pluripotent mouse teratocarcinoma cell line TCE.
    Wobus AM; Holzhausen H; Bloch C; Intek A; Becker K; Walter G; Forejt J; Schöneich J
    Biomed Biochim Acta; 1985; 44(11-12):1609-20. PubMed ID: 4091834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of protein phosphatase inhibition by okadaic acid on the differentiation of F9 embryonal carcinoma cells.
    Nishina Y; Sumi T; Iwai SA; Nishimune Y
    Exp Cell Res; 1995 Apr; 217(2):288-93. PubMed ID: 7698228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait.
    Oshima RG; McKerrow J; Cox D
    J Cell Physiol; 1981 Nov; 109(2):195-204. PubMed ID: 7197684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of F9 cell differentiation by transient exposure to retinoic acid.
    Dong JM; Li F; Chiu JF
    Biochem Biophys Res Commun; 1990 Jul; 170(1):147-52. PubMed ID: 1695505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hybrids between F9 "nullipotent" teratocarcinoma and rat thymus cells produce differentiated cells].
    Hsu WM; Song QB; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):177-87. PubMed ID: 3835750
    [No Abstract]   [Full Text] [Related]  

  • 36. Teratocarcinoma differentiation: plasminogen activator activity associated with embryoid body formation.
    Linney E; Levinson BB
    Cell; 1977 Feb; 10(2):297-304. PubMed ID: 189937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a human ovarian teratocarcinoma-derived cell line.
    Zeuthen J; Nørgaard JO; Avner P; Fellous M; Wartiovaara J; Vaheri A; Rosén A; Giovanella BC
    Int J Cancer; 1980 Jan; 25(1):19-32. PubMed ID: 6931103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse embryonal carcinoma (F9) cells.
    Tsuneizumi K; Kume T; Watanabe T; Gebbink MF; Thomas ML; Oishi M
    FEBS Lett; 1994 Jun; 347(1):9-12. PubMed ID: 8013668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.
    Kondo K; Tsuneizumi K; Watanabe T; Oishi M
    Cancer Res; 1991 Oct; 51(19):5398-404. PubMed ID: 1680548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.